BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19223857)

  • 1. Tumor suppressor protein C53 antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activation.
    Jiang H; Wu J; He C; Yang W; Li H
    Cell Res; 2009 Apr; 19(4):458-68. PubMed ID: 19223857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint.
    Jiang H; Luo S; Li H
    J Biol Chem; 2005 May; 280(21):20651-9. PubMed ID: 15790566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of LHBs with C53 promotes hepatocyte mitotic entry: A novel mechanism for HBV-induced hepatocellular carcinoma.
    Lei Y; Liu H; Yang Y; Wang X; Ren N; Li B; Liu S; Cheng J; Fu X; Zhang J
    Oncol Rep; 2012 Jan; 27(1):151-9. PubMed ID: 21971960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.
    Castedo M; Perfettini JL; Roumier T; Yakushijin K; Horne D; Medema R; Kroemer G
    Oncogene; 2004 May; 23(25):4353-61. PubMed ID: 15048074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel positive feedback loop between Cdk1 and Chk1 in the nucleus during G2/M transition.
    Enomoto M; Goto H; Tomono Y; Kasahara K; Tsujimura K; Kiyono T; Inagaki M
    J Biol Chem; 2009 Dec; 284(49):34223-30. PubMed ID: 19837665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling.
    Wu J; Lei G; Mei M; Tang Y; Li H
    J Biol Chem; 2010 May; 285(20):15126-15136. PubMed ID: 20228063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase.
    Krämer A; Mailand N; Lukas C; Syljuåsen RG; Wilkinson CJ; Nigg EA; Bartek J; Lukas J
    Nat Cell Biol; 2004 Sep; 6(9):884-91. PubMed ID: 15311285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF inhibits the activity of the cyclin B1/CDK1 kinase to induce a transient G₂arrest in RCS chondrocytes.
    Tran T; Kolupaeva V; Basilico C
    Cell Cycle; 2010 Nov; 9(21):4379-86. PubMed ID: 21051949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FRET-Based Sorting of Live Cells Reveals Shifted Balance between PLK1 and CDK1 Activities During Checkpoint Recovery.
    Lafranchi L; Müllers E; Rutishauser D; Lindqvist A
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RRM1 maintains centrosomal integrity via CHK1 and CDK1 signaling during replication stress.
    Kim SH; Park ER; Joo HY; Shen YN; Hong SH; Kim CH; Singh R; Lee KH; Shin HJ
    Cancer Lett; 2014 May; 346(2):249-56. PubMed ID: 24434653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damage.
    Cazales M; Schmitt E; Montembault E; Dozier C; Prigent C; Ducommun B
    Cell Cycle; 2005 Sep; 4(9):1233-8. PubMed ID: 16082213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.
    Deming PB; Flores KG; Downes CS; Paules RS; Kaufmann WK
    J Biol Chem; 2002 Sep; 277(39):36832-8. PubMed ID: 12147700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrosomal Che-1 protein is involved in the regulation of mitosis and DNA damage response by mediating pericentrin (PCNT)-dependent Chk1 protein localization.
    Sorino C; Bruno T; Desantis A; Di Certo MG; Iezzi S; De Nicola F; Catena V; Floridi A; Chessa L; Passananti C; Cundari E; Fanciulli M
    J Biol Chem; 2013 Aug; 288(32):23348-57. PubMed ID: 23798705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling.
    Jurvansuu J; Fragkos M; Ingemarsdotter C; Beard P
    J Mol Biol; 2007 Sep; 372(2):397-406. PubMed ID: 17663993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear Chk1 prevents premature mitotic entry.
    Matsuyama M; Goto H; Kasahara K; Kawakami Y; Nakanishi M; Kiyono T; Goshima N; Inagaki M
    J Cell Sci; 2011 Jul; 124(Pt 13):2113-9. PubMed ID: 21628425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms.
    Sanchez Y; Bachant J; Wang H; Hu F; Liu D; Tetzlaff M; Elledge SJ
    Science; 1999 Nov; 286(5442):1166-71. PubMed ID: 10550056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemis links ATM to G2/M checkpoint recovery via regulation of Cdk1-cyclin B.
    Geng L; Zhang X; Zheng S; Legerski RJ
    Mol Cell Biol; 2007 Apr; 27(7):2625-35. PubMed ID: 17242184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human decatenation checkpoint.
    Deming PB; Cistulli CA; Zhao H; Graves PR; Piwnica-Worms H; Paules RS; Downes CS; Kaufmann WK
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12044-9. PubMed ID: 11593014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
    Tsvetkov L; Stern DF
    Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.